Pmh42 - Cost-Utility Analysis of Cariprazine Compared to Risperidone Among Patients With Negative Symptoms of Schizophrenia in Selected Nordic Countries
Value in Health - United Kingdom
doi 10.1016/j.jval.2018.09.1677
Full Text
Open PDFAbstract
Available in full text
Date
October 1, 2018
Authors
Publisher
Elsevier BV